GBA1 and Parkinson disease: This effect was dependent on mutation severity, since a significant increase in phospho-Ser129 α-syn was primarily seen after administration of EVs isolated from PD fibroblasts carrying the L444P mutation compared both to NM-PD and to carriers of mild GBA mutation N370S (p < 0.05) (Figure 3B).